WO2022208144A1 - A crystalline form of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride and method thereof - Google Patents
A crystalline form of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride and method thereof Download PDFInfo
- Publication number
- WO2022208144A1 WO2022208144A1 PCT/IB2021/055010 IB2021055010W WO2022208144A1 WO 2022208144 A1 WO2022208144 A1 WO 2022208144A1 IB 2021055010 W IB2021055010 W IB 2021055010W WO 2022208144 A1 WO2022208144 A1 WO 2022208144A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- reaction mass
- chlorophenyl
- methylamino
- temperature
- range
- Prior art date
Links
- VCMGMSHEPQENPE-UHFFFAOYSA-N ketamine hydrochloride Chemical compound [Cl-].C=1C=CC=C(Cl)C=1C1([NH2+]C)CCCCC1=O VCMGMSHEPQENPE-UHFFFAOYSA-N 0.000 title claims abstract description 78
- 238000000034 method Methods 0.000 title claims abstract description 38
- 238000006243 chemical reaction Methods 0.000 claims abstract description 114
- 230000008569 process Effects 0.000 claims abstract description 30
- 238000001816 cooling Methods 0.000 claims abstract description 29
- 238000010438 heat treatment Methods 0.000 claims abstract description 24
- 238000001035 drying Methods 0.000 claims abstract description 20
- 238000001914 filtration Methods 0.000 claims abstract description 18
- 238000005406 washing Methods 0.000 claims abstract description 15
- 239000003960 organic solvent Substances 0.000 claims abstract description 14
- 239000002002 slurry Substances 0.000 claims abstract description 13
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims abstract description 10
- ZBPVOOPHLCDCEQ-UHFFFAOYSA-N cyclopentanol;hydrochloride Chemical compound Cl.OC1CCCC1 ZBPVOOPHLCDCEQ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 102
- 239000013078 crystal Substances 0.000 claims description 64
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000000047 product Substances 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 17
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 16
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical group ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 238000004821 distillation Methods 0.000 claims description 8
- 239000012452 mother liquor Substances 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- 238000003801 milling Methods 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 3
- 229960004184 ketamine hydrochloride Drugs 0.000 description 13
- UPXRTVAIJMUAQR-UHFFFAOYSA-N 4-(9h-fluoren-9-ylmethoxycarbonylamino)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound C1C(C(O)=O)N(C(=O)OC(C)(C)C)CC1NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 UPXRTVAIJMUAQR-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 3
- 229920001903 high density polyethylene Polymers 0.000 description 3
- 239000004700 high-density polyethylene Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- -1 crystals Chemical compound 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- YQEZLKZALYSWHR-ZDUSSCGKSA-N (S)-ketamine Chemical compound C=1C=CC=C(Cl)C=1[C@@]1(NC)CCCCC1=O YQEZLKZALYSWHR-ZDUSSCGKSA-N 0.000 description 1
- PXXNTAGJWPJAGM-VCOUNFBDSA-N Decaline Chemical compound C=1([C@@H]2C3)C=C(OC)C(OC)=CC=1OC(C=C1)=CC=C1CCC(=O)O[C@H]3C[C@H]1N2CCCC1 PXXNTAGJWPJAGM-VCOUNFBDSA-N 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 241001272720 Medialuna californiensis Species 0.000 description 1
- JXVIIQLNUPXOII-UHFFFAOYSA-N Siduron Chemical compound CC1CCCCC1NC(=O)NC1=CC=CC=C1 JXVIIQLNUPXOII-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- AYOOGWWGECJQPI-NSHDSACASA-N n-[(1s)-1-(5-fluoropyrimidin-2-yl)ethyl]-3-(3-propan-2-yloxy-1h-pyrazol-5-yl)imidazo[4,5-b]pyridin-5-amine Chemical compound N1C(OC(C)C)=CC(N2C3=NC(N[C@@H](C)C=4N=CC(F)=CN=4)=CC=C3N=C2)=N1 AYOOGWWGECJQPI-NSHDSACASA-N 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Definitions
- Embodiment of the present disclosure relates to a different crystalline forms of 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride and method of preparing the same.
- Ketamine hydrochloride is a nonbarbiturate anaesthetic used for diagnostic and surgical procedures, with a wide range of effects in humans such as confusion, hallucinations, light-headedness, weak breathing,
- US 3254124 discloses the thermal rearrangement of l-hydroxycyclopentyl-(o- Chlorophenyl)-Ketone N-Methylamine at reflux (boiling point about 190°C) for two hours in decaline.
- US20140275276A1 discloses an aqueous formulation of S-Ketamine Hydrochloride, preferably for nasal administration and that the formulation does not contain an antimicrobial preservative.
- the presently available process are costlier and less-efficient in consumption of utilities to obtain ketamine hydrochloride.
- the processes in the state-of-art cannot synthesize different types of crystals required for different formulations. Therefore, there is a need for an alternative low-cost and effective process for obtaining new crystalline form of ketamine hydrochloride synthesis.
- a process for preparing a crystalline form of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprising addition of l-[-(2-chlorophenyl) (methylamine) methyl] cyclopentanol hydrochloride to a first organic solvent to obtain a reaction mass, heating the reaction mass in a temperature range of 160°C to 165°C for a predetermined time period to obtain a slurry reaction mass, wherein the obtained slurry reaction mass is dissolved and a crystalline form is isolated from the reaction mass, cooling the isolated crystalline form in the temperature range of 20°C to 25°C, filtering and washing the isolated crystalline form with a second organic solvent and drying the isolated crystalline form at 70°C to 80°C up to a constant weight to obtain 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
- the first organic solvent is ortho dichlorobenzene in the range of 3 to 3.5 volume.
- the predetermined time period is 30 mins.
- the second organic solvent is acetone in the range of 0.3 to 0.5 volume.
- the one or more polymorphs of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride are in the form of a small crystals, a sugar like crystals, a rock candy like crystals and a needle like crystals.
- processing the 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to obtain one or more polymorphs comprises of adding the obtained 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to water, heating the reaction mass at a temperature range of 40°C to 50°C followed by activated carbon treatment, filtering the reaction mass, followed by cooling temperature range of 10°C to 15°C, and adjusting the pH to be in the range of 9.5 to 10 by addition of liquid ammonia and the reaction mass was continuously stirred for at least 30 minutes at a temperature range of 10°C to 15°C; and filtering the ketamine base and washed with water to obtain a wet 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone.
- the process of preparation of the small crystal like polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding of wet 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone to 4.0% to 6.0% aqueous isopropyl alcohol to obtain a reaction mass, adjusting the moisture of the reaction mass to 8.0% to 10%, heating the reaction mass at a temperature in the range of 60°C to 65°C followed by activated carbon treatment, cooling the carbon treated filtrate at a temperature of 15°C to 20°C and adjusting the pH to 0.8 to 1.5 by addition of isopropyl alcohol and hydrochloric acid solution, distillation of the isopropyl alcohol from the reaction mass, cooling the reaction mass at a temperature in the range of 5°C to 10°C, filtering the reaction mass to isolate the product and drying the isolated product at a temperature in the range of 80°C to 85
- the process of preparation of sugar like crystal polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding the wet 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone to 4.0% to 6.0% an aqueous isopropyl alcohol to obtain a reaction mass, adjusting the moisture of the reaction mass to 8.0% to 10.0%, heating the reaction mass at a temperature in the range of 60°C to 65°C followed by activated carbon treatment, cooling the carbon treated reaction mass at a temperature in the range of 15°C to 20°C and adjusting the pH to 0.8 to 1.5 by addition of isopropyl alcohol and hydrochloric acid, heating the reaction mass at a temperature of 78°C and adding of demineralized water to dissolve the solids followed by distillation of isopropyl alcohol to obtain the slurry at the same temperature, cooling the reaction mass at a temperature in the range
- the process of preparation of rock candy crystal like polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding of 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride to methanol, heating the reaction mass at a temperature in the range of 60°C to 65°C, cooling the reaction mass overnight and removing rock candy like crystals, concentrating the mother liquor at a temperature of 45°C under vacuum till occurrence of turbidity, heating the reaction mass at a temperature of 60°C to 65°C to get clear reaction mass, cooling the reaction mass overnight without any disturbance and drying, milling and sieving to obtain rock candy like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
- the process of preparation of needle like crystal polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding of the 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride to a demineralized water at a room temperature, heating the reaction mass at a temperature in the range of 60°C to 75°C for achieving complete dissolution, cooling the reaction mass at a temperature in the range of 55°C for 24 to 26 hours, adding water to the reaction mass at regular intervals to cool the contents at a temperature in the range of 30°C to 40°C for over 10 to 18 hours, filtering the isolated needle type crystal by washing with isopropyl alcohol, collecting water from the mother liquor and repeating the previous steps for seven times and drying and sieving the needle like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochlor
- FIG. 1 illustrates a flow chart depicting process for preparing a crystalline form of a 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride
- FIG. 2 shows small crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure
- FIG. 3 shows sugar like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone Hydrochloride in accordance with an embodiment of the present disclosure
- FIG. 4 shows rock candy like crystals 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure
- FIG. 5 shows needle like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure
- ketamine hydrochloride refers to a prescription medicine used as a sedative for diagnostic and surgical procedures. It is a nonbarbiturate anaesthetic chemically as designated dl 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
- FIG. 1 illustrates a flow chart depicting process for preparing a crystalline form of a 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
- step 102 it involves addition of a l-[-(2-chlorophenyl) (methylamine) methyl] cyclopentanol hydrochloride to a first organic solvent to obtain a reaction mass, wherein the first organic solvent is ortho dichlorobenzene in the range of 3 to 3.5 volume.
- step 104 it involves heating the reaction mass at a temperature range of 160°C to 165°C for a predetermined time period to obtain a slurry reaction mass, wherein the obtained slurry reaction mass is dissolved and a product is isolated from the reaction mass, wherein the predetermined time period is 30mins.
- step 106 involves cooling the isolated product at a temperature range of 20°C to 25°C.
- step 108 filtering and washing the isolated product with a second organic solvent, wherein the second organic solvent is acetone in range of 0.3 to 0.5 volume.
- step 110 drying the isolated product at a temperature range of 70°C to 80°C up to a constant weight to obtain the crystalline form of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
- step 112 processing the 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to obtain one or more polymorphs, wherein the one or more polymorphs of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride are in the form of a small crystals, a sugar like crystals, a rock candy like crystals and a needle like crystals.
- Ketamine base was filtered followed by washing with water (200 litre) and total yield of 290 to 330 kg of wet 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone Shall be consumed for next steps in preparation of one or more crystalline forms of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
- FIG. 2 shows small crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure.
- the process of preparation of the small crystal like polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding of wet 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone to 4.0% to 6.0% aqueous isopropyl alcohol to obtain a reaction mass, adjusting the moisture of the reaction mass to 8.0% to 10%, heating the reaction mass at a temperature in the range of 60°C to 65°C followed by activated carbon treatment, cooling the carbon treated filtrate at a temperature of 15°C to 20°C and adjusting the pH to 0.8 to 1.5 by addition of isopropyl alcohol and hydrochloric acid solution, distillation of the isopropyl alcohol from the reaction mass, cooling the reaction
- reaction mass was maintained for 30mins followed by the distillation of isopropyl alcohol from reaction mass to about 2000 litres to 2300 litres atmospherically. Next, the reaction mass was then chilled to 5°C to 10°C. The isolated material is then filtered followed by chilled IPA washing. Finally, after drying the isolated material at temperature range of 85°C, the small Crystals of 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride (Ketamine Hydrochloride) was obtained and the total yield rate is about 87.50% (525 kg).
- FIG. 3 shows sugar like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure.
- the process for preparation of the sugar like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding the wet 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone to 4.0% to 6.0% an aqueous isopropyl alcohol to obtain a reaction mass, adjusting the moisture of the reaction mass to 8.0% to 10.0%, heating the reaction mass at a temperature in the range of 60°C to 65°C followed by activated carbon treatment, cooling the carbon treated reaction mass at a temperature in the range of 15°C to 20°C and adjusting the pH to 0.8 to 1.5 by addition of isopropyl alcohol and hydrochloric acid, heating the reaction mass at a temperature of 78°C and
- the carbon treated filtrate was further chilled to a temperature in the range of 15°C to 20°C and acidified to pH 0.8 to 1.5 by Isopropyl alcohol + Hydrochloric acid solution (NLT 24.0 % of HC1 content by titration) at a temperature in the range of 15°C to 20°C.
- the reaction was maintained for 30 minutes.
- the reaction mass was heated to a temperature in the range of 78°C and demineralized water was added just to dissolve the solid (8% to 15%) followed by the distillation of Isopropyl alcohol atmospherically from the reaction mass to obtain the slurry at the same temperature.
- the reaction mass was then chilled to a temperature in the range of 25°C to 30°C.
- the isolated material was filtered, followed by chilled IPA washing.
- FIG. 4 shows rock candy like crystals 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure.
- one or more polymorphs can be obtained as rock candy like crystals by dissolving the 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in three fold volume of methanol at a temperature in the range of 60°C to 65°C, wherein the crystals can be obtained without disturbing the reaction mass for a time period of 20 to 40 hours.
- the process comprises of adding of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to methanal, heating the reaction mass at a temperature in the range of 60°C to 65°C, cooling the reaction mass overnight and removing rock candy like crystals, concentrating the mother liquor at a temperature of 45°C under vacuum till occurrence of turbidity, heating the reaction mass at a temperature of 60°C to 65°C to get clear reaction mass, cooling the reaction mass overnight without any disturbance and drying, milling and sieving to obtain rock candy like crystals of 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride.
- Ketamine Hydrochloride obtained from Example - 3 was added to methanol. Steam was applied to heat the reaction mass at 60°C to 65°C. The clear reaction mass was then transferred hot in the HDPE (High Density Polyethylene) drums. The contents from the drums was allowed to cool overnight naturally without disturbing, this may get prolonged to get the desired crystals. The rock candy like crystals formed are removed from drams. The Mother liquor was concentrated up to 45°C under vacuum till turbidity occurred. Again, the reaction mass is heated to 60°C to 65°C to get clear reaction mass. Then reaction mass was transferred to HDPE drums followed by naturally cooling for overnight or more time without disturbing. After drying, milling & sieving the rock candy like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone Hydrochloride was obtained.
- HDPE High Density Polyethylene
- FIG. 5 shows needle like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure.
- needle shaped crystals can be obtained by dissolving the 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in a volume of water (1.7 folds) at a temperature in the range of 70°C to 75°C.
- the reaction mass is agitated continuously at the rate of 100 and subsequently cooled slowly up to a temperature of 55°C in a time period of 24 to 26 hours and then up to 30°C to 40°C in 10 to 18 hours.
- the process of preparation of needle like crystal polymorph of 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding of the 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to a demineralized water at a room temperature, heating the reaction mass at a temperature in the range of 60°C to 75°C for achieving complete dissolution, cooling the reaction mass at a temperature in the range of 55°C in 24 to 26 hours, adding water to the reaction mass at regular intervals to cool the contents at a temperature in the range of 30°C to 40°C for over 10 to 18 hours, filtering the isolated needle type crystal by washing with isopropyl alcohol, collecting water from the mother liquor and repeating the previous steps for seven times; and drying and sieving the needle like crystals of 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride.
- the room temperature water was applied for 10 minutes to reaction mass at the regular intervals of every hour to cool the content to a temperature in the range of 30°C to 40°C (more preferably to 40°C) in 10 to 18 hours.
- the isolated needle type crystal was then filtered through nutsche filter followed by washing with 30 litre filtered Isopropyl alcohol.
- the water from the mother liquor was collected through cartridge filter in the same assembly.
- 100 kg of Ketamine Hydrochloride obtained from the method described in the Example - 3 was added.
- the reaction mass was heated to 60°C to 75°C to make it completely dissolved.
- the RPM of a stirrer was adjusted to 100. Then the reaction mass was allowed to cool to a temperature of 55°C in 24 to 26 hours naturally.
- the room temperature water was applied for 10 minutes to the reaction mass at the intervals of every hour to cool the content to 30°C to 40°C (more preferably to 40°C) in 10 to 18 hours.
- the isolated needle type crystal was then filtered through nutsche filter followed by washing with filtered Isopropyl alcohol. Like this 100 kg of Ketamine Hydrochloride top up was done up to VII lots.
- the Needles obtained thus was dried carefully in a trey dryer at a temperature in the range of 60°C to 75°C followed by sieving. (70% to 90% of the Input Quantity).
- the crystalline form of a 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride obtained using the process of present invention is cheaper, efficient and further different types of crystals required for different formulations can be obtained.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A process for preparing a crystalline form of a 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride, comprising addition of a 1-[-(2-chlorophenyl) (methylamine) methyl] cyclopentanol hydrochloride to a first organic solvent to obtain a reaction mass, heating the reaction mass at a temperature range of 160°C to 165°C for a predetermined time period to obtain a slurry reaction mass, wherein the obtained slurry reaction mass is dissolved and a product is isolated from the reaction mass, cooling the isolated product at a temperature range of 20°C to 25°C, filtering and washing the isolated product with a second organic solvent, drying the isolated product at a temperature range of 70°C to 80°C up to a constant weight to obtain the crystalline form of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride and processing the 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to obtain one or more crystalline forms. The total yield of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride using the process is 88%.
Description
A CRYSTALLINE FORM OF 2-(2-CHLOROPHENYL)-2-(METHYLAMINO) CYCLOHEXANONE HYDROCHLORIDE AND METHOD THEREOF
This International Application claims priority from a Complete patent application filed in India having Patent Application No. 202121015070, filed on March 31, 2021, and titled “A CRYSTALLINE FORM OF 2-(2-CHLOROPHENYL)-2-(METHYLAMINO) CYCLOHEXANONE HYDROCHLORIDE AND METHOD THEREOF”.
FIELD OF INVENTION
Embodiment of the present disclosure relates to a different crystalline forms of 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride and method of preparing the same.
BACKGROUND OF THE INVENTION
Ketamine hydrochloride is a nonbarbiturate anaesthetic used for diagnostic and surgical procedures, with a wide range of effects in humans such as confusion, hallucinations, light-headedness, weak breathing,
US 3254124 discloses the thermal rearrangement of l-hydroxycyclopentyl-(o- Chlorophenyl)-Ketone N-Methylamine at reflux (boiling point about 190°C) for two hours in decaline.
US20140275276A1 discloses an aqueous formulation of S-Ketamine Hydrochloride, preferably for nasal administration and that the formulation does not contain an antimicrobial preservative. The presently available process are costlier and less-efficient in consumption of utilities to obtain ketamine hydrochloride. Also, the processes in the state-of-art cannot synthesize different types of crystals required for different formulations. Therefore, there is a need for an alternative low-cost and effective process for obtaining new crystalline form of ketamine hydrochloride synthesis.
SUMMARY OF THE INVENTION
In accordance with an embodiment of the present invention, a process for preparing a crystalline form of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride, comprising addition of l-[-(2-chlorophenyl) (methylamine) methyl] cyclopentanol hydrochloride to a first organic solvent to obtain a reaction mass, heating the reaction mass in a temperature range of 160°C to 165°C for a predetermined time period to obtain a slurry reaction mass, wherein the obtained slurry reaction mass is dissolved and a crystalline form is isolated from the reaction mass, cooling the isolated crystalline form in the temperature range of 20°C to 25°C, filtering and washing the isolated crystalline form with a second organic solvent and drying the isolated crystalline form at 70°C to 80°C up to a constant weight to obtain 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
In accordance with an embodiment of the present invention, wherein the first organic solvent is ortho dichlorobenzene in the range of 3 to 3.5 volume.
In accordance with an embodiment of the present invention, wherein the predetermined time period is 30 mins.
In accordance with an embodiment of the present invention, wherein the second organic solvent is acetone in the range of 0.3 to 0.5 volume.
In accordance with an embodiment of the present invention, wherein the total yield of 2- (2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride is 88%.
In accordance with an embodiment of the present invention, wherein the one or more polymorphs of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride are in the form of a small crystals, a sugar like crystals, a rock candy like crystals and a needle like crystals.
In accordance with an embodiment of the present invention, wherein processing the 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to obtain one or more polymorphs comprises of adding the obtained 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to water, heating the reaction mass at a temperature range of 40°C to 50°C followed by activated carbon treatment, filtering the reaction mass, followed by cooling temperature range of 10°C to 15°C, and adjusting the pH to be in the range of 9.5 to 10 by addition of liquid ammonia and the reaction mass was continuously stirred for at least 30 minutes at a temperature range of 10°C to 15°C; and filtering the ketamine base and washed with water to obtain a wet 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone.
In accordance to an embodiment of the present invention, wherein the process of preparation of the small crystal like polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding of wet 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone to 4.0% to 6.0% aqueous isopropyl alcohol to obtain a reaction mass, adjusting the moisture of the reaction mass to 8.0% to 10%, heating the reaction mass at a temperature in the range of 60°C to 65°C followed by activated carbon treatment, cooling the carbon treated filtrate at a temperature of 15°C to 20°C and adjusting the pH to 0.8 to 1.5 by addition of isopropyl alcohol and hydrochloric acid solution, distillation of the isopropyl alcohol from the reaction mass, cooling the reaction mass at a temperature in the range of 5°C to 10°C, filtering the reaction mass to isolate the product and drying the isolated product at a temperature in the range of 80°C to 85°C to obtain small crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
In accordance to an embodiment of the present invention, wherein the process of preparation of sugar like crystal polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding the wet 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone to 4.0% to 6.0% an aqueous isopropyl alcohol to obtain a reaction mass, adjusting the moisture of the reaction mass to 8.0% to 10.0%, heating the reaction mass at a temperature in the range of 60°C to 65°C followed by activated carbon
treatment, cooling the carbon treated reaction mass at a temperature in the range of 15°C to 20°C and adjusting the pH to 0.8 to 1.5 by addition of isopropyl alcohol and hydrochloric acid, heating the reaction mass at a temperature of 78°C and adding of demineralized water to dissolve the solids followed by distillation of isopropyl alcohol to obtain the slurry at the same temperature, cooling the reaction mass at a temperature in the range of 25°C to 30°C, filtering to isolate the product and followed by IPA washing at a lower temperature, drying the isolated product at a temperature in the range of 80°C to 85°C to obtain sugar like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
In accordance to an embodiment of the present invention, wherein the process of preparation of rock candy crystal like polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding of 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride to methanol, heating the reaction mass at a temperature in the range of 60°C to 65°C, cooling the reaction mass overnight and removing rock candy like crystals, concentrating the mother liquor at a temperature of 45°C under vacuum till occurrence of turbidity, heating the reaction mass at a temperature of 60°C to 65°C to get clear reaction mass, cooling the reaction mass overnight without any disturbance and drying, milling and sieving to obtain rock candy like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
In accordance with an embodiment of the present invention, wherein the process of preparation of needle like crystal polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding of the 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride to a demineralized water at a room temperature, heating the reaction mass at a temperature in the range of 60°C to 75°C for achieving complete dissolution, cooling the reaction mass at a temperature in the range of 55°C for 24 to 26 hours, adding water to the reaction mass at regular intervals to cool the contents at a temperature in the range of 30°C to 40°C for over 10 to 18 hours, filtering the isolated needle type crystal by washing with isopropyl alcohol, collecting water from the mother liquor and repeating the previous steps for seven times and drying and sieving
the needle like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
To further clarify the advantages and features of the present disclosure, a more particular description of the disclosure will follow by reference to specific embodiments thereof, which are illustrated in the appended figures. It is to be appreciated that these figures depict only typical embodiments of the disclosure and are therefore not to be considered limiting in scope. The disclosure will be described and explained with additional specificity and detail with the appended figures.
BRIEF DESCRIPTION OF THE DRAWINGS
The disclosure will be described and explained with additional specificity and detail with the accompanying figures in which: FIG. 1 illustrates a flow chart depicting process for preparing a crystalline form of a 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride;
FIG. 2 shows small crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure;
FIG. 3 shows sugar like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone Hydrochloride in accordance with an embodiment of the present disclosure;
FIG. 4 shows rock candy like crystals 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure;
FIG. 5 shows needle like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure;
Further, those skilled in the art will appreciate that elements in the figures are illustrated for simplicity and may not have necessarily been drawn to scale. Furthermore, in terms of the construction of the device, one or more components of the device may have been represented in the figures by conventional symbols, and the figures may show only those specific details that are pertinent to understanding the embodiments of the present disclosure so as not to obscure the figures with details that will be readily apparent to those skilled in the art having the benefit of the description herein.
DETAILED DESCRIPTION OF THE INVENTION For the purpose of promoting an understanding of the principles of the disclosure, reference will now be made to the embodiment illustrated in the figures and specific language will be used to describe them. It will nevertheless be understood that no limitation of the scope of the disclosure is thereby intended. Such alterations and further modifications in the illustrated system, and such further applications of the principles of the disclosure as would normally occur to those skilled in the art are to be construed as being within the scope of the present disclosure.
The terms "comprises", "comprising", or any other variations thereof, are intended to cover a non-exclusive inclusion, such that a process or method that comprises a list of steps does not include only those steps but may include other steps not expressly listed or inherent to such a process or method. Appearances of the phrase "in an embodiment", "in another embodiment" and similar language throughout this specification may, but not necessarily do, all refer to the same embodiment. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which this disclosure belongs. The examples provided herein are only illustrative and not intended to be limiting.
In the following specification and the claims, reference will be made to a number of terms, which shall be defined to have the following meanings. The singular forms “a”, “an”, and “the” include plural references unless the context clearly dictates otherwise.
As used herein, the term “ketamine hydrochloride” refers to a prescription medicine used as a sedative for diagnostic and surgical procedures. It is a nonbarbiturate anaesthetic chemically as designated dl 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
FIG. 1 illustrates a flow chart depicting process for preparing a crystalline form of a 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride. According to an embodiment of the present invention, thermal rearrangement of 1 -hydroxycyclopentyl-(0- chlorophenyl)-ketone-N-methy limine hydrochloride by using ortho dichlorobenzene to obtain 2-(2-chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride.
According to an embodiment of the present invention, at step 102, it involves addition of a l-[-(2-chlorophenyl) (methylamine) methyl] cyclopentanol hydrochloride to a first organic solvent to obtain a reaction mass, wherein the first organic solvent is ortho dichlorobenzene in the range of 3 to 3.5 volume.
At step 104, it involves heating the reaction mass at a temperature range of 160°C to 165°C for a predetermined time period to obtain a slurry reaction mass, wherein the obtained slurry reaction mass is dissolved and a product is isolated from the reaction mass, wherein the predetermined time period is 30mins.
At step 106, involves cooling the isolated product at a temperature range of 20°C to 25°C.
At step 108, filtering and washing the isolated product with a second organic solvent, wherein the second organic solvent is acetone in range of 0.3 to 0.5 volume.
At step 110, drying the isolated product at a temperature range of 70°C to 80°C up to a constant weight to obtain the crystalline form of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
At step 112, processing the 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to obtain one or more polymorphs, wherein the one or more polymorphs of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride are in the form of a small crystals, a sugar like crystals, a rock candy like crystals and a needle like crystals.
EXAMPLE 1
Preparation of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone Hydrochloride
In a reactor, 420 kg l-[-(2-chlorophenyl) (methylamino) methyl] cyclopentanol hydrochloride was added to 1260 litre of Ortho dichlorobenzene. The reaction mass is heated to 160°C to 165°C for 30 minutes. The slurry reaction mass was dissolved & then got isolated from the reaction. Cooling was applied to 20°C to 25°C followed by filtration & 150 litre Acetone wash. After drying at 70°C to 80°C up to a constant weight, 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone Hydrochloride was obtained.
EXAMPLE-2
Preparation of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone In a reactor, 300 kg of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride was added to 1800 litre of process water. The reaction mass was hated to a temperature in the range of 40°C to 50°C followed by 5 kg of Activated carbon treatment. The clear filtrate obtained after carbon treatment was cooled to 10°C to 15°C then basified to pH 9.5 to 10 by hquor ammonia reaction mass and further stirred for 30 minutes at a temperature in the range of 10°C to 15°C. The isolated Ketamine base was filtered followed by washing with water (200 litre) and total yield of 290 to 330 kg of wet 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone Shall be consumed for next steps in
preparation of one or more crystalline forms of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
FIG. 2 shows small crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure. According to an embodiment of the present invention, the process of preparation of the small crystal like polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding of wet 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone to 4.0% to 6.0% aqueous isopropyl alcohol to obtain a reaction mass, adjusting the moisture of the reaction mass to 8.0% to 10%, heating the reaction mass at a temperature in the range of 60°C to 65°C followed by activated carbon treatment, cooling the carbon treated filtrate at a temperature of 15°C to 20°C and adjusting the pH to 0.8 to 1.5 by addition of isopropyl alcohol and hydrochloric acid solution, distillation of the isopropyl alcohol from the reaction mass, cooling the reaction mass at a temperature in the range of 5°C to 10°C, filtering the reaction mass to isolate the product and drying the isolated product at a temperature in the range of 80°C to 85°C to obtain small crystals of 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride.
EXAMPLE-3
Preparation of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone Hydrochloride (Ketamine hydrochloride) Small Crystals
In reactor, wet 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone (600kg on dry basis) to 2100 litres of 4.0% to 6.0% aqueous isopropyl alcohol. Next, the moisture of the reaction mass is heated to a temperature in the range of 60°C to 65°C followed by 15kg of activated carbon treatment. Further, the carbon treated filtrate is chilled in the temperature range of 15°C to 20°C and acidified to pH 0.8 to 1.5 by addition of isopropyl alcohol and hydrochloric acid solution (NLT 24.0% of HCL content by titration) at temperature range of 15°C to 20°C. The resultant reaction mass was maintained for 30mins followed by the distillation of isopropyl alcohol from reaction mass to about 2000 litres to 2300 litres atmospherically. Next, the reaction mass was then chilled to 5°C to 10°C. The isolated material is then filtered followed by chilled IPA washing. Finally, after drying the isolated material at temperature range of 85°C, the small Crystals of 2-(2-
chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride (Ketamine Hydrochloride) was obtained and the total yield rate is about 87.50% (525 kg).
FIG. 3 shows sugar like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure. According to an embodiment of the present invention, the process for preparation of the sugar like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding the wet 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone to 4.0% to 6.0% an aqueous isopropyl alcohol to obtain a reaction mass, adjusting the moisture of the reaction mass to 8.0% to 10.0%, heating the reaction mass at a temperature in the range of 60°C to 65°C followed by activated carbon treatment, cooling the carbon treated reaction mass at a temperature in the range of 15°C to 20°C and adjusting the pH to 0.8 to 1.5 by addition of isopropyl alcohol and hydrochloric acid, heating the reaction mass at a temperature of 78°C and adding of demineralized water to dissolve the solids followed by distillation of isopropyl alcohol to obtain the slurry at the same temperature, cooling the reaction mass at a temperature in the range of 25°C to 30°C, filtering to isolate the product and followed by IPA (Isopropyl alcohol) washing at a lower temperature, drying the isolated product at a temperature in the range of 80°C to 85°C to obtain sugar like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
EXAMPLE-4
Preparation of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone Hydrochloride (Ketamine hydrochloride) Sugar Like Crystals In a reactor, wet 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone obtained from Example - 2, 600 kg (on dry basis) was added to 2100 litre of 4.0% to 6.0% aqueous Isopropyl Alcohol. The moisture of reaction mass was adjusted to 8.0% to 10.0%. The reaction mass was heated to a temperature in the range of 60°C to 65°C followed by 15 kg of activated carbon treatment. The carbon treated filtrate was further chilled to a temperature in the range of 15°C to 20°C and acidified to pH 0.8 to 1.5 by Isopropyl alcohol + Hydrochloric acid solution (NLT 24.0 % of HC1 content by titration) at a temperature in the range of 15°C to 20°C. The reaction was maintained for 30 minutes. The reaction mass was heated to a temperature in the range of 78°C and demineralized
water was added just to dissolve the solid (8% to 15%) followed by the distillation of Isopropyl alcohol atmospherically from the reaction mass to obtain the slurry at the same temperature. The reaction mass was then chilled to a temperature in the range of 25°C to 30°C. The isolated material was filtered, followed by chilled IPA washing. After drying at a temperature in the range of 80°C to 85°C, the sugar like crystals of 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride (Ketamine hydrochloride) was obtained.
FIG. 4 shows rock candy like crystals 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure. According to an embodiment of the present invention, one or more polymorphs can be obtained as rock candy like crystals by dissolving the 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in three fold volume of methanol at a temperature in the range of 60°C to 65°C, wherein the crystals can be obtained without disturbing the reaction mass for a time period of 20 to 40 hours. More specifically, the process comprises of adding of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to methanal, heating the reaction mass at a temperature in the range of 60°C to 65°C, cooling the reaction mass overnight and removing rock candy like crystals, concentrating the mother liquor at a temperature of 45°C under vacuum till occurrence of turbidity, heating the reaction mass at a temperature of 60°C to 65°C to get clear reaction mass, cooling the reaction mass overnight without any disturbance and drying, milling and sieving to obtain rock candy like crystals of 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride.
EXAMPLE-5
Preparation of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride
Rock Candy Like Crystals
Ketamine Hydrochloride obtained from Example - 3 was added to methanol. Steam was applied to heat the reaction mass at 60°C to 65°C. The clear reaction mass was then transferred hot in the HDPE (High Density Polyethylene) drums. The contents from the drums was allowed to cool overnight naturally without disturbing, this may get prolonged
to get the desired crystals. The rock candy like crystals formed are removed from drams. The Mother liquor was concentrated up to 45°C under vacuum till turbidity occurred. Again, the reaction mass is heated to 60°C to 65°C to get clear reaction mass. Then reaction mass was transferred to HDPE drums followed by naturally cooling for overnight or more time without disturbing. After drying, milling & sieving the rock candy like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone Hydrochloride was obtained.
FIG. 5 shows needle like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in accordance with an embodiment of the present disclosure. According to an embodiment of the present invention, needle shaped crystals can be obtained by dissolving the 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride in a volume of water (1.7 folds) at a temperature in the range of 70°C to 75°C. The reaction mass is agitated continuously at the rate of 100 and subsequently cooled slowly up to a temperature of 55°C in a time period of 24 to 26 hours and then up to 30°C to 40°C in 10 to 18 hours.
More specifically, the process of preparation of needle like crystal polymorph of 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of adding of the 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to a demineralized water at a room temperature, heating the reaction mass at a temperature in the range of 60°C to 75°C for achieving complete dissolution, cooling the reaction mass at a temperature in the range of 55°C in 24 to 26 hours, adding water to the reaction mass at regular intervals to cool the contents at a temperature in the range of 30°C to 40°C for over 10 to 18 hours, filtering the isolated needle type crystal by washing with isopropyl alcohol, collecting water from the mother liquor and repeating the previous steps for seven times; and drying and sieving the needle like crystals of 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride.
EXAMPLE-6
Preparation of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone Hydrochloride
Needle Like Crystals
In a 0.5 KL of single walled glass assembly immersed in a water bath, fitted with motor operated overhead stirrer, two half-moon type Teflon blades, 200 kg of Ketamine Hydrochloride obtained from Example - 3 was added to 340 litre demineralized water at room temperature. The reaction mass was heated to a temperature in the range of 60°C to 75°C to make it completely dissolved. The RPM (revolutions per minute) of a stirrer was adjusted to be at 100. Then the reaction mass was allowed to cool to a temperature of 55°C in 24 to 26 hours naturally. The room temperature water was applied for 10 minutes to reaction mass at the regular intervals of every hour to cool the content to a temperature in the range of 30°C to 40°C (more preferably to 40°C) in 10 to 18 hours. The isolated needle type crystal was then filtered through nutsche filter followed by washing with 30 litre filtered Isopropyl alcohol. The water from the mother liquor was collected through cartridge filter in the same assembly. To this 100 kg of Ketamine Hydrochloride obtained from the method described in the Example - 3 was added. The reaction mass was heated to 60°C to 75°C to make it completely dissolved. The RPM of a stirrer was adjusted to 100. Then the reaction mass was allowed to cool to a temperature of 55°C in 24 to 26 hours naturally. The room temperature water was applied for 10 minutes to the reaction mass at the intervals of every hour to cool the content to 30°C to 40°C (more preferably to 40°C) in 10 to 18 hours. The isolated needle type crystal was then filtered through nutsche filter followed by washing with filtered Isopropyl alcohol. Like this 100 kg of Ketamine Hydrochloride top up was done up to VII lots. The Needles obtained thus was dried carefully in a trey dryer at a temperature in the range of 60°C to 75°C followed by sieving. (70% to 90% of the Input Quantity).
The crystalline form of a 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride obtained using the process of present invention is cheaper, efficient and further different types of crystals required for different formulations can be obtained.
While specific language has been used to describe the disclosure, any limitations arising on account of the same are not intended. As would be apparent to a person skilled in the
art, various working modifications may be made to the method in order to implement the inventive concept as taught herein.
The figures and the foregoing description give examples of embodiments. Those skilled in the art will appreciate that one or more of the described elements may well be combined into a single functional element. Alternatively, certain elements may be split into multiple functional elements. Elements from one embodiment may be added to another embodiment. For example, order of processes described herein may be changed and are not limited to the manner described herein. Moreover, the actions of any flow diagram need not be implemented in the order shown; nor do all of the acts need to be necessarily performed. Also, those acts that are not dependant on other acts may be performed in parallel with the other acts. The scope of embodiments is by no means limited by these specific examples.
Claims
1. A process for preparing a crystalline form of a 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride, comprising: addition of a l-[-(2-chlorophenyl) (methylamine) methyl] cyclopentanol hydrochloride to a first organic solvent to obtain a reaction mass; heating the reaction mass at a temperature range of 160°C to 165°C for a predetermined time period to obtain a slurry reaction mass, wherein the obtained slurry reaction mass is dissolved and a product is isolated from the reaction mass; cooling the isolated product at a temperature range of 20°C to 25°C; filtering and washing the isolated product with a second organic solvent; drying the isolated product at a temperature range of 70°C to 80°C up to a constant weight to obtain the crystalline form of 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride; and processing the 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to obtain one or more crystalline forms.
2. The process as claimed in claim 1, wherein the first organic solvent is ortho dichlorobenzene in the range of 3 to 3.5 volume.
3. The process as claimed in claim 1, wherein the predetermined time period is
30mins.
4. The process as claimed in claim 1, wherein the second organic solvent is acetone in the range of 0.3 to 3.5 volume.
5. The process as claimed in claim 1, wherein the one or more polymorphs of 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride are in the form of a
small crystals, a sugar like crystals, a rock candy like crystals and a needle like crystals.
6. The process as claimed in claim 1, wherein processing the 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride to obtain one or more crystalline forms comprises of: adding the obtained 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to water; heating the reaction mass at a temperature range of 40°C to 50°C followed by activated carbon treatment; cooling the reaction mass at a temperature range of 10°C to 15°C; filtering the reaction mass and adjusting the pH to be in the range of 9.5 to 10 by addition of liquid ammonia and the reaction mass was continuously stirred for at least 30minutes at a temperature range of 10°C to 15°C; and filtering the ketamine base and washed with water to obtain a wet 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone.
7. The process as claimed in claim 6, wherein the process of preparation of the small crystal like polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of: adding of wet 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone to 4.0% to 6.0% aqueous isopropyl alcohol to obtain a reaction mass; adjusting the moisture of the reaction mass to 8.0% to 10%; heating the reaction mass at a temperature in the range of 60°C to 65°C followed by activated carbon treatment; cooling the carbon treated filtrate at a temperature of 15°C to 20°C and adjusting the pH to 0.8 to 1.5 by addition of isopropyl alcohol and hydrochloric acid solution; distillation of the isopropyl alcohol from the reaction mass; cooling the reaction mass at a temperature in the range of 5°C to 10°C; filtering the reaction mass to isolate the product; and
drying the isolated product at a temperature in the range of 80°C to 85°C to obtain small crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone Hydrochloride.
8. The process as claimed in claim 6, wherein the process of preparation of sugar like crystal form of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of: adding the wet 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone to 4.0% to 6.0% an aqueous isopropyl alcohol to obtain a reaction mass; adjusting the moisture of the reaction mass to 8.0% to 10.0%; heating the reaction mass at a temperature in the range of 60°C to 65°C followed by activated carbon treatment; cooling the carbon treated reaction mass at a temperature in the range of 15°C to 20°C and adjusting the pH to 0.8 to 1.5 by addition of isopropyl alcohol and hydrochloric acid; heating the reaction mass at a temperature of 78°C and adding of demineralized water to dissolve the solids (water content 8% to 15%) followed by distillation of isopropyl alcohol to obtain the slurry at the same temperature; cooling the reaction mass at a temperature in the range of 25°C to 30°C; filtering to isolate the product and followed by IPA washing at a lower temperature; drying the isolated product at a temperature in the range of 80°C to 85°C to obtain sugar like crystals of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
9. The process as claimed in claim 6, wherein the process of preparation of rock candy crystal like polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of: adding of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to methanol; heating the reaction mass at a temperature in the range of 60°C to 65°C;
cooling the reaction mass overnight and removing rock candy like crystals; concentrating the mother liquor at a temperature of 45°C under vacuum till occurrence of turbidity; heating the reaction mass at a temperature of 60°C to 65°C to get clear reaction mass; cooling the reaction mass overnight without any disturbance; drying, milling and sieving to obtain rock candy like crystals of 2-(2- chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride.
10. The process as claimed in claim 6, wherein the process of preparation of needle like crystal polymorph of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride comprises of: a) adding of the 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride to a demineralized water (1.5 volume to 2.0 volume) at a room temperature; b) heating the reaction mass at a temperature in the range of 60°C to 75°C for achieving complete dissolution; c) cooling the reaction mass at a temperature in the range of 55°C for 24 to 26 hours; d) adding water to a Jacket at regular intervals to cool the contents at a temperature in the range of 30°C to 40°C for over 10 to 18 hours; e) filtering the isolated needle type crystal by washing with isopropyl alcohol; f) collecting water from the mother liquor and repeating the steps (a) to (e) for seven times; and g) drying and sieving the needle like crystals of 2-(2-chlorophenyl)-2- (methylamino) cyclohexanone hydrochloride;
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202121015070 | 2021-03-31 | ||
IN202121015070 | 2021-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022208144A1 true WO2022208144A1 (en) | 2022-10-06 |
Family
ID=83458139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2021/055010 WO2022208144A1 (en) | 2021-03-31 | 2021-06-08 | A crystalline form of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride and method thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022208144A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3254124A (en) * | 1962-06-29 | 1966-05-31 | Parke Davis & Co | Aminoketones and methods for their production |
US20160332962A1 (en) * | 2015-05-13 | 2016-11-17 | Janssen Pharmaceutica Nv | (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine |
WO2020212510A1 (en) * | 2019-04-16 | 2020-10-22 | Janssen Pharmaceutica Nv | Synthetic methods of preparing esketamine |
-
2021
- 2021-06-08 WO PCT/IB2021/055010 patent/WO2022208144A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3254124A (en) * | 1962-06-29 | 1966-05-31 | Parke Davis & Co | Aminoketones and methods for their production |
US20160332962A1 (en) * | 2015-05-13 | 2016-11-17 | Janssen Pharmaceutica Nv | (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine |
WO2020212510A1 (en) * | 2019-04-16 | 2020-10-22 | Janssen Pharmaceutica Nv | Synthetic methods of preparing esketamine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1914212B (en) | Polymorphic forms of a GABAA agonist | |
FI116840B (en) | Photochemical cross-linked polysaccharide derivatives as a basis for chromatographic separation of enantiomers | |
EP2297092A1 (en) | Polymorphic and amorphous forms of lacosamide and amorphous compositions | |
CN105061416B (en) | A kind of method for preparing flumioxazin | |
JP3972229B2 (en) | Method for producing ε-polymorphic hexanitrohexaazai Seoul titanium | |
CN105669679A (en) | Preparation method of PCI-32765 crystal form A | |
Karashima et al. | Rational polymorph screening based on slow cooling crystallization of poorly soluble mebendazole | |
WO2014041566A2 (en) | An improved process for the preparation of metformin hydrochloride | |
WO2022208144A1 (en) | A crystalline form of 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride and method thereof | |
CN105294809A (en) | Method for preparing tauro ursodesoxy cholic acid | |
CA3077506A1 (en) | New salt and solid state forms of escitalopram | |
CN116621817B (en) | Entecavir fumarate crystal form, preparation method, pharmaceutical composition and application thereof | |
EP2658840B1 (en) | Process for making fingolimod hydrochloride crystals | |
CN107531744A (en) | A kind of new crystalline form of shellfish cholic acid difficult to understand and preparation method thereof | |
EP3002286B1 (en) | Preparation method for polymorphic 6-(4-chlorophenoxy)-tetrazolo[5,1-a]phthalazine and use thereof | |
CN109689620B (en) | Method for resolving baclofen salt | |
CA2575376A1 (en) | Novel crystalline forms of 6alpha, 9alpha-difluoro-11beta hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxy-androsta-1,4-diene-17beta-carboxylic acid and processes for preparationthereof | |
JP2022514909A (en) | Preparation process of anthranilamide | |
CN105294689B (en) | Tetra-substituted pyrazol isoquinoline compound and synthetic method thereof | |
CN115850105B (en) | Co-crystal of methyldopa and proline as well as preparation method and application thereof | |
EP4188905B1 (en) | Method for the purification of vilanterol trifenatate | |
JP2019525946A (en) | Method for producing hydronidone | |
CN110396106B (en) | Imidazole [1,5-a ] pyridinium salt and preparation method and application thereof | |
CN106749075A (en) | Crystal formation of oxazolidone intermediate of Ah Nagqu ripple and preparation method thereof | |
RU2227141C2 (en) | Method for preparing benzylamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21934734 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21934734 Country of ref document: EP Kind code of ref document: A1 |